Nearly three out of five biopharma professionals (58%) believe their company’s potential is restricted by rigidity in daily strategic decision-making.  Research commissioned by Nmblr revealed that strategic misalignment is endemic across the industry, threatening both speed to market and the ability to adapt in real-time.   The survey found that poor cross-functional alignment (47%), inadequate up-front […]